Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion

Date:




Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Diesel Buyers Compete for Shrinking Supply Pool

Diesel buyers are competing for shrinking supply amid disruptions...

Transfer rumors, news: Galatasaray offer Bruno Fernandes double his salary

Aug 18, 2026, 03:27 AM ETManchester United midfielder Bruno...

Student shooter kills classmate and himself at Philippine school

Student shooter kills classmate and himself at a Philippine...